Accelerate to discover
Related topics
Spectral data analysis webinar recording - Cytek flow cytometer and De Novo Software
Jan 17, 2019
Cytek Biosciences and De Novo Software are proud to announce a collaboration that allows you to work with your spectral...
Improved differentiation of Retinal Organoids stem cells derived using rotating-wall vessels
Jan 15, 2019
Pluripotent stem cells can be differentiated into 3D retinal organoids, with major cell types self-patterning into a...
IncuCyte webinar recording: CAR T-cell therapy, frontiers in cancer Immunotherapy
Jan 11, 2019
The success of immune checkpoint blockade adds new therapeutic category to Cancers are the most heterogenous group of...
Xcell Bio webinar: AVATAR system, to control cell state to get better cells, fast
Oct 30, 2018
Dr. Schneider will show examples of data from customers who have incorporated pressure along with oxygen to recreate...
Understanding subtle cardiac changes
Oct 3, 2018
Are you working with high ultrasound imaging and are you interesting in VevoStrain application and specific changes in...
Contrast-enhanced ultrasound imaging
Sep 5, 2018
Are you interested in photoacoustic imaging and would like to enhance your contrast imaging acquisitions? Just use...
Aug 9, 2018
We bring you the latest KOL interview on the Albira Si PET/SPECT/CT from Prof. John Prior, CHUV Lausanne. He describes...
Webinar Tuning Microenvironment to Control Cells for Improved Disease Modeling & Immunotherapy Work
Jul 16, 2018
The company producing Avatar, xCELL biosciences have organized a webinar about the tuning of microenvironment to...
Nov 22, 2018
Researchers developed an assay to measure CLL cell interactions with endothelium under shear force using a Bioflux 200 and blocked CD62L using the anti-CD62L antibody DREG-56. CLL cell interactions with endothelium were visualized by time-lapse microscopy and CLL cell movement was tracked and quantified. Data will be discussed in the webinar and will establish targeting CD62L inhibits CLL cell/endothelial cell interactions and is accentuated by co-administration with ibrutinib. These data imply that some of the clinical effects caused by ibrutinib are due to a reduced capacity of CLL cells to engage endothelium and extravasate.
Dr. Chris Pepper, Professor in Cancer Studies, University of Sussex, UK
Related technologies: Cell interaction studies
Get more info
Brand profile
With BioFlux System for live cell analysis under shear flow and IsoFlux System for circulating tumor cell analysis, Fluxion Biosciences turn power of benchtop cellular analysis with advanced tools to automate complex assays.
More info at:
www.fluxionbio.com
BioFocus newsletter
Register to receive Brand new technology development, Important product updates, Interesting scientific events and more!
BioTech a.s. © 2014
Designed & developed by imagineit
Technologies
